COVID-19: Understanding What We Know After Five Years .

COVID-19: Understanding What We Know After Five Years

# COVID-19: Understanding What We Know After Five Years

 

Five years after COVID-19 transformed everyday life around the world, the pandemic can sometimes feel like a distant chapter. Masks are no longer a routine part of daily life in most places. Hospitals are no longer overwhelmed in the way they were during the worst waves. Vaccination has become part of routine health care in many countries, and governments have largely shifted from emergency measures to long-term management.

 

But COVID-19 has not disappeared.

 

The virus SARS-CoV-2 continues to circulate, people still become seriously ill, and some continue to experience symptoms long after their initial infection. At the same time, scientists have learned an extraordinary amount about the virus, treatments, vaccines, transmission and the lasting effects of the pandemic.

 

Five years on, the picture is more complicated than either “COVID is over” or “nothing has changed.”

 

The truth lies somewhere in between.

 

## From Global Emergency to Long-Term Health Challenge

 

The World Health Organization declared COVID-19 a pandemic on March 11, 2020. More than three years later, in May 2023, WHO ended the COVID-19 public health emergency of international concern.

 

That decision did not mean SARS-CoV-2 had vanished. Instead, it reflected a fundamental change in the global situation.

 

By then, widespread immunity from vaccination and previous infections, improved clinical management, better access to testing and the evolution of the virus had changed the level of risk for much of the population.

 

WHO’s later assessments have continued to describe COVID-19 as a significant health concern even though its impact has decreased compared with the early pandemic years. Organisation mondiale de la santé+1

 

In other words, COVID-19 has moved from being an unprecedented emergency toward becoming a continuing respiratory disease that health systems must manage alongside other infectious illnesses.

 

That transition is one of the most important things we have learned.

 

## The Virus Is Still With Us

 

One misconception is that ending the emergency meant ending the disease.

 

It did not.

 

SARS-CoV-2 continues to evolve and circulate. New lineages emerge, and immunity from previous infection or vaccination can decline over time.

 

The good news is that the combination of population immunity, vaccines and improved medical care has substantially reduced the risk of severe outcomes for many people.

 

WHO reported that the global public-health impact decreased during 2023 and 2024, driven in part by widespread immunity, the characteristics of circulating variants and improvements in diagnosis and clinical care. Organisation mondiale de la santé

 

But reduced risk is not the same as zero risk.

 

COVID-19 can still cause hospitalization and death, particularly among older adults, people with certain underlying conditions and people with weakened immune systems.

 

A 2025 WHO fact sheet estimated that nearly 780 million reported cases and more than 7.1 million reported deaths had occurred worldwide since December 2019, while emphasizing that the actual totals are higher because reporting is incomplete. Organisation mondiale de la santé

 

The scale of the pandemic therefore remains enormous.

 

## Vaccines Changed the Course of the Pandemic

 

One of the clearest scientific achievements of the COVID-19 era was the rapid development and deployment of effective vaccines.

 

COVID-19 vaccines did not make infection impossible, and they were never a guarantee that someone would not transmit the virus. Their most important benefit has been protection against severe disease and death.

 

WHO continues to report that approved COVID-19 vaccines provide protection against severe disease and death. Organisation mondiale de la santé

 

That understanding has also changed how vaccination is approached.

 

Rather than treating everyone as having identical risk, current recommendations increasingly focus on people most likely to experience severe illness.

 

WHO’s 2026 recommendations call on countries to consider routine vaccination for groups at highest risk, including the oldest adults, certain older people with significant medical conditions, residents of long-term-care facilities and moderately or severely immunocompromised individuals. Organisation mondiale de la santé+1